Lanwei Guo

3.1k total citations
108 papers, 1.6k citations indexed

About

Lanwei Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Lanwei Guo has authored 108 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 37 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Lanwei Guo's work include Colorectal Cancer Screening and Detection (18 papers), Gastric Cancer Management and Outcomes (18 papers) and Esophageal Cancer Research and Treatment (17 papers). Lanwei Guo is often cited by papers focused on Colorectal Cancer Screening and Detection (18 papers), Gastric Cancer Management and Outcomes (18 papers) and Esophageal Cancer Research and Treatment (17 papers). Lanwei Guo collaborates with scholars based in China, United States and Canada. Lanwei Guo's co-authors include Shuzheng Liu, Shaokai Zhang, Qiong Chen, Peiliang Quan, Min Dai, Xi‐Bin Sun, Jie He, Jian-Bang Lu, Ni Li and Jiansong Ren and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gut.

In The Last Decade

Lanwei Guo

97 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanwei Guo China 21 656 457 354 324 235 108 1.6k
Muneer J. Al‐Husseini Egypt 15 629 1.0× 395 0.9× 333 0.9× 297 0.9× 155 0.7× 38 1.3k
Seri Hong South Korea 19 549 0.8× 434 0.9× 275 0.8× 297 0.9× 253 1.1× 47 1.5k
Bingfeng Han China 13 509 0.8× 382 0.8× 203 0.6× 349 1.1× 213 0.9× 34 1.6k
Claire Jones Canada 15 939 1.4× 412 0.9× 451 1.3× 459 1.4× 200 0.9× 53 1.9k
Fay Cafferty United Kingdom 22 523 0.8× 578 1.3× 410 1.2× 401 1.2× 293 1.2× 56 2.0k
Kengo Nagashima Japan 25 715 1.1× 617 1.4× 523 1.5× 259 0.8× 237 1.0× 191 2.0k
Hyeong Su Kim South Korea 24 650 1.0× 615 1.3× 308 0.9× 437 1.3× 124 0.5× 117 1.7k
Alessio Cortellini Italy 22 1.1k 1.6× 426 0.9× 158 0.4× 332 1.0× 222 0.9× 130 1.7k
Ting Zhou China 24 974 1.5× 586 1.3× 227 0.6× 531 1.6× 292 1.2× 117 2.0k
Beth Barber United States 24 712 1.1× 418 0.9× 322 0.9× 218 0.7× 138 0.6× 83 2.1k

Countries citing papers authored by Lanwei Guo

Since Specialization
Citations

This map shows the geographic impact of Lanwei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanwei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanwei Guo more than expected).

Fields of papers citing papers by Lanwei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanwei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanwei Guo. The network helps show where Lanwei Guo may publish in the future.

Co-authorship network of co-authors of Lanwei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Lanwei Guo. A scholar is included among the top collaborators of Lanwei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanwei Guo. Lanwei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fang, Qigen, Junhui Yuan, Xu Zhang, Tao Huang, & Lanwei Guo. (2025). Response-adapted surgery after neoadjuvant immunochemotherapy in oral squamous cell carcinoma. Oral Oncology. 171. 107769–107769.
3.
Guo, Lanwei, Zhangyan Lyu, Qingcheng Meng, et al.. (2025). The probability of lung cancer in patients with pulmonary nodules detected via low-dose computed tomography screening in China. BMC Cancer. 25(1). 1058–1058.
4.
Zhang, Xiaojuan, Mina Zhang, Xinyang Du, et al.. (2024). Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer. Frontiers in Pharmacology. 15. 1331138–1331138. 5 indexed citations
5.
Hu, Dongsheng, Yaping Liu, Ling Yang, et al.. (2023). Sporadic lymphangioleiomyomatosis in a man with somatic mosaicism of TSC2 mutations, a case report. QJM. 117(1). 75–76.
6.
Guo, Lanwei, Qingcheng Meng, Liyang Zheng, et al.. (2023). Lung Cancer Risk Prediction Nomogram in Nonsmoking Chinese Women: Retrospective Cross-sectional Cohort Study. JMIR Public Health and Surveillance. 9. e41640–e41640. 4 indexed citations
7.
Yin, Jian, Gang Wang, Zheng Wu, et al.. (2022). Association Between Baseline C-Reactive Protein and the Risk of Lung Cancer: A Prospective Population-Based Cohort Study. Cancer Prevention Research. 15(11). 747–754. 2 indexed citations
8.
Guo, Lanwei, et al.. (2021). [Compliance rate and impact factor analysis of liver cancer screening in urban areas of Henan Province].. PubMed. 43(2). 233–237. 4 indexed citations
10.
Xu, Huifang, Maria José González, Lanwei Guo, et al.. (2020). Knowledge, Awareness, and Attitudes Relating to the COVID-19 Pandemic Among Different Populations in Central China: Cross-Sectional Survey. Journal of Medical Internet Research. 22(10). e22628–e22628. 26 indexed citations
11.
Zhang, Kai, Jian Yin, Huiyao Huang, et al.. (2020). Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study. Frontiers in Public Health. 8. 310–310. 13 indexed citations
12.
Chen, Hongda, Ni Li, Jiansong Ren, et al.. (2018). Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 68(8). 1450–1457. 213 indexed citations
13.
Guo, Lanwei, Shuzheng Liu, Meng Zhang, et al.. (2017). [Multivariate ordinal logistic regression analysis on the association between consumption of fried food and both esophageal cancer and precancerous lesions].. PubMed. 38(12). 1616–1619. 4 indexed citations
14.
Guo, Lanwei, Huiyao Huang, Le Wang, et al.. (2017). [Economic burden of esophageal cancer in China from 1996 to 2015: a systematic review].. PubMed. 38(1). 102–109. 8 indexed citations
15.
Chen, Qiong, Changqing Hao, Jinwu Wang, et al.. (2016). Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case–control study. Cancer Medicine. 5(9). 2615–2622. 45 indexed citations
16.
Zhang, Meng, Xin Li, Shaokai Zhang, et al.. (2016). [Analysis of the efficacy of gastric cancer screening in rural population in Henan Province].. PubMed. 38(1). 73–7. 6 indexed citations
17.
Guo, Lanwei, Shuzheng Liu, Shaokai Zhang, et al.. (2016). Human papillomavirus-related esophageal cancer survival. Medicine. 95(46). e5318–e5318. 18 indexed citations
18.
Shi, Jufang, Huiyao Huang, Lanwei Guo, et al.. (2015). [Acceptance and willingness-to-pay for colorectal colonoscopy screening among high-risk populations for colorectal cancer in urban China].. PubMed. 49(5). 381–6. 7 indexed citations
19.
Zhang, Shaokai, Lanwei Guo, Qiong Chen, et al.. (2015). The association between human papillomavirus 16 and esophageal cancer in Chinese population: a meta-analysis. BMC Cancer. 15(1). 1096–1096. 165 indexed citations
20.
Zhang, Shaokai, Lanwei Guo, Qiong Chen, et al.. (2015). Prevalence of Human Papillomavirus 16 in Esophageal Cancer Among the Chinese Population: a Systematic Review and Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(23). 10143–10149. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026